Cala ONE Device for Essential Tremor
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02629614 |
Recruitment Status :
Completed
First Posted : December 14, 2015
Results First Posted : July 18, 2023
Last Update Posted : July 18, 2023
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Participant, Outcomes Assessor); Primary Purpose: Treatment |
Condition |
Essential Tremor |
Intervention |
Device: Cala ONE Device |
Enrollment | 93 |
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | TAPS Stimulation | Sham Stimulation |
---|---|---|
![]() |
Temporal Afferent Patterned Stimulation (TAPS) is alternating bursts of TENS stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device. Cala ONE Device: The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes. |
0 amplitude stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device. Cala ONE Device: The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes. |
Period Title: Overall Study | ||
Started | 48 | 45 |
Completed | 48 | 44 |
Not Completed | 0 | 1 |
Arm/Group Title | TAPS Stimulation | Sham Stimulation | Total | |
---|---|---|---|---|
![]() |
Temporal Afferent Patterned Stimulation (TAPS) is alternating bursts of TENS stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device. Cala ONE Device: The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes. |
0 amplitude stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device. Cala ONE Device: The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes. |
Total of all reporting groups | |
Overall Number of Baseline Participants | 48 | 45 | 93 | |
![]() |
[Not Specified]
|
|||
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 48 participants | 45 participants | 93 participants | |
<=18 years |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Between 18 and 65 years |
12 25.0%
|
12 26.7%
|
24 25.8%
|
|
>=65 years |
36 75.0%
|
33 73.3%
|
69 74.2%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||||
Number Analyzed | 48 participants | 45 participants | 93 participants | |
70.5 (11.2) | 69.8 (10.1) | 70.2 (10.6) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 48 participants | 45 participants | 93 participants | |
Female |
25 52.1%
|
23 51.1%
|
48 51.6%
|
|
Male |
23 47.9%
|
22 48.9%
|
45 48.4%
|
|
Ethnicity (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 48 participants | 45 participants | 93 participants | |
Hispanic or Latino |
2 4.2%
|
0 0.0%
|
2 2.2%
|
|
Not Hispanic or Latino |
45 93.8%
|
45 100.0%
|
90 96.8%
|
|
Unknown or Not Reported |
1 2.1%
|
0 0.0%
|
1 1.1%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 48 participants | 45 participants | 93 participants | |
American Indian or Alaska Native |
0 0.0%
|
1 2.2%
|
1 1.1%
|
|
Asian |
0 0.0%
|
1 2.2%
|
1 1.1%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Black or African American |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
White |
47 97.9%
|
41 91.1%
|
88 94.6%
|
|
More than one race |
1 2.1%
|
2 4.4%
|
3 3.2%
|
|
Unknown or Not Reported |
0 0.0%
|
0 0.0%
|
0 0.0%
|
Name/Title: | Sr. Director of Clinical Operations |
Organization: | Cala Health |
Phone: | 6506515296 |
EMail: | vivien@calahealth.com |
Responsible Party: | Cala Health, Inc. |
ClinicalTrials.gov Identifier: | NCT02629614 |
Other Study ID Numbers: |
ET-03 |
First Submitted: | December 8, 2015 |
First Posted: | December 14, 2015 |
Results First Submitted: | June 1, 2023 |
Results First Posted: | July 18, 2023 |
Last Update Posted: | July 18, 2023 |